首页> 外文OA文献 >Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study

【2h】

Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study

机译：生物学有效剂量和肿瘤对照阶段I（<5cm）非小细胞肺癌肿瘤对照与立体定向烧蚀放疗：单一制度队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wan Jeon; Sung-Ja Ahn; Young-Chul Kim; In-Jae Oh; Chul-Kyu Park; Jae-Uk Jeong; Mee Sun Yoon; Ju-Young Song; Taek-Keun Nam; Woong-Ki Chung;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study [J] . WanJeon, Sung-JaAhn, Young-ChulKim, Japanese journal of clinical oncology. . 2018,第2期

机译：生物学有效剂量和肿瘤对照阶段I（<5cm）非小细胞肺癌肿瘤对照的相关性，具有立体定向化放射治疗：单一制度队列研究
2. Biologically Effective Dose and the Tumor Control in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: Comparison of Isocenter- and PTV-Based Prescription Methods [J] . Ikawa T., Wada K., Kanayama N., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：用立体定向体放射治疗治疗的早期非小细胞肺癌的生物学有效剂量和肿瘤对照：基于Isocenter和PTV的处方方法比较
3. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [J] . M. P. Snee, L. McParland, F. Collinson, Pilot and Feasibility Studies . 2016,第1期

机译：SABRTooth可行性试验方案：一项研究，用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除引起并发症的风险更高
4. Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR) [C] . S Devpura, M S Siddiqui, D Chen, ICCR . 2014

机译：肺癌治疗计划剂量计算的建议（SABR）治疗肺癌治疗计划（SABR）
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [O] . M. P. Snee, L. McParland, F. Collinson, 2016

机译：SABRTooth可行性试验方案：一项研究用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除并发症的风险更高
7. Biologically Effective Dose and the Tumor Control in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: Comparison of Isocenter- and PTV-Based Prescription Methods [O] . T. Ikawa, K. Wada, N. Kanayama, 2018

机译：用立体定向体放射治疗治疗的早期非小细胞肺癌的生物学有效剂量和肿瘤对照：基于Isocenter和PTV的处方方法比较
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study

著录项

引文网络

相似文献

相关主题

期刊订阅